Abstract: The oblong bulb (1) of the lamp is sealed at opposing ends by sealing pieces (6; 32), with application of a holder to each end, whereby said holder comprises an electrical contact element (13; 25), electrically connected to a power supply (15; 21), running to the lighting means. The contact element is housed in a tubular extension (11; 22) of the sealing piece and the maximum external diameter of the contact element (13; 25) is loosely matched to the inner diameter of the sleeve.

Abstract: This invention provides novel aryl piperazine derivatives represented by Formula (I) having medical utility, in particular as modulators of dopamine and serotonin receptors, preferably the D3, 5HT1A and 5-HT2A receptor subtypes, and in particular useful for the treatment of neuropsychiatric disorders, incl. schizophrenia.

Abstract: Reconstituted bacterial replication assemblies and methods for their use are provided.

Abstract: A polynucleotide isolated from cotton plants capable of initiating transcription and with sequence identity to SEQ ID No.1 is provided. In some aspects, the polynucleotide has sequence identity to SEQ ID No. 1 of at least 40%, is the reverse complement or the reverse of such sequences. In some aspects, the polynucleotide is linked to expression enhancers or sequences of interest. In some embodiments, a recombinant vector comprises the polynucleotide. In some aspects, the recombinant vector comprises enhancers, termination sequences, or sequences of interest. In some embodiments a transformed cell, plant, plant part, or propagulum comprise the polynucleotide.

Abstract: A vehicle door articulating and sliding mechanism is provided that includes a swing arm pivotally mounted via a first bracket to a vehicle structure at one end and a sliding assembly comprising a rotating second bracket mounted at an opposite end of the swing arm. The sliding assembly is slidably engaged to a vehicle door. The mechanism also includes a first flexible link at least partially encircling a first sprocket connected to the vehicle structure and a second sprocket fixed to the vehicle door. The mechanism further includes a second flexible link fixed to the vehicle door at one end and fixed to the vehicle structure at the opposite end. The second flexible link at least partially encircles a cam, wherein the first flexible link and cam provide a catch that engages the cam to accelerate movement of the door during opening.

Abstract: The present invention provides novel heterocyclic urea compounds having useful antibacterial activity, pharmaceutical compositions comprising one or more of these compounds, methods of making the same, and methods of using the same.

Abstract: A method, apparatus (100) and system (200) for altering the playback speed of recorded content (105) to match a target syllable rate is provided. A user may enter a desired, target playback syllable rate through a user interface (101), such as a keypad or touch screen. Alternatively, the target playback syllable rate may be determined from identification of the source of the recorded content (105). An actual playback syllable rate (106) associated with the recorded content (105) is then determined. The recorded content (105) is then altered, by time domain harmonic scaling in one embodiment, such that the altered playback speed (109) substantially matches the target playback syllable rate. In so doing, a listener is able to receive recorded content (105) at a faster or slower rate than it is produced.

Abstract: The invention relates to a passivated hydrogenation catalyst that is embedded in a primary amine, a derivative thereof, and/or a nitrile, the process to make such catalysts, as well as the use of such catalysts in a hydrogenation process in which an amine or a derivative thereof is produced.

Abstract: The oblong bulb (1) of the lamp is sealed at opposing ends by sealing pieces (6; 32), with application of a holder to each end, whereby said holder comprises an electrical contact element (13; 25), electrically connected to a power supply (15; 21), running to the lighting means. The contact element is housed in a tubular extension (11; 22) of the sealing piece and the maximum external diameter of the contact element (13; 25) is loosely matched to the inner diameter of the sleeve.

Abstract: This invention relates to novel chemically-modified nucleic acid molecules having specified formulae that exhibit increased resistance to nucleases and increased binding affinity to target nucleic acid molecules. The invention further relates to methods of modulating gene expression using the novel chemically modified nucleic acid molecules, and compositions and cells comprising said molecules.

Abstract: The invention relates to a passivated hydrogenation catalyst that is embedded in a primary amine, a derivative thereof, and/or a nitrile, the process to make such catalysts, as well as the use of such catalysts in a hydrogenation process in which an amine or a derivative thereof is produced.

Abstract: An enzymatic nucleic acid molecule comprising a 5?- and/or a 3?-cap structure, wherein said structure is not a 5?-5?-linked inverted nucleotide or a 3?-3?-linked inverted nucleotide.

Abstract: Systems, methods, and data structures are described which allow or caching streaming media file in a manner that allows for storage and retrieval of portions of the streaming media file that are temporally non-contiguous and/or encoded at differing bit rates.

Abstract: A method for controlling and managing individual directed sessions between at least two endpoints in a communications system. The method including the steps of: intercepting a first message sent from an initiating endpoint via application layer routing to at least one other endpoint requesting an individual directed session; communicating the requested individual directed session to a service entity for determining the state of the session as a function of communication system resources and capabilities and resources of the endpoints to be included in the requested session, and if the requested individual directed session is accepted determining a set of corresponding session parameters; and communicating the state of the requested individual session to the initiating endpoint via application layer routing, and if the requested session is accepted also communicating the state of the session the at least one other endpoint via application layer routing.

Abstract: A communication system includes a vehicle (101) and an infrastructure (160). The vehicle contains vehicle system information (104) and user information (112). The infrastructure includes a processor (154) with an applications program (155). The application is arranged to remotely access (200, 300, 400 and 500) the vehicle system information in a secure manner. The application is also arranged to remotely access (600) the user information in a secure manner.

Abstract: A method for controlling and managing individual directed sessions between at least two endpoints in a communications system. The method including the steps of: intercepting a first message sent from an initiating endpoint via application layer routing to at least one other endpoint requesting an individual directed session; communicating the requested individual directed session to a service entity for determining the state of the session as a function of communication system resources and capabilities and resources of the endpoints to be included in the requested session, and if the requested individual directed session is accepted determining a set of corresponding session parameters; and communicating the state of the requested individual session to the initiating endpoint via application layer routing, and if the requested session is accepted also communicating the state of the session the at least one other endpoint via application layer routing.

Abstract: This invention relates to novel chemically-modified nucleic acid molecules having specific formulae that exhibit increased resistance to nucleases and increased binding affinity to target nucleic acid molecules. The invention further relates to methods of modulating gene expression using the novel chemically modified nucleic acid molecules, and compositions and cells comprising said molecules.

Abstract: The present invention relates to nucleic acid molecules which block synthesis and/or expression of an mRNA encoding B7-1, B7-2, B7-3 and/or CD40.

Abstract: A telematics communication system (100) includes an infrastructure (140) and a vehicle (102), the vehicle including at least one in-vehicle system (104, 118) and a wireless gateway (120) in communication with an authenticated vehicle gateway (108). The authenticated vehicle gateway authenticates the wireless gateway and the at least one in-vehicle system and processes service requests and authenticated service grants for the authenticated wireless gateway and the authenticated in-vehicle system.

Abstract: The present invention relates to nucleic acid molecules, including antisense and enzymatic nucleic acid molecules, such as hammerhead ribozymes, DNAzymes, and antisense, which modulate the expression of the GRID (Grb2-related with Insert Domain) gene.